Literature DB >> 30344351

Selective, C-3 Friedel-Crafts acylation to generate functionally diverse, acetylated Imidazo[1,2-a]pyridine derivatives.

Brendan Frett1, Nicholas McConnell2, Anupreet Kharbanda1, Gunaganti Naresh1, Benjamin Rounseville2, Christina Warner2, John Chang2, Natalie Debolske2, Hong-Yu Li1.   

Abstract

Carbon-carbon bonds are integral for pharmaceutical discovery and development. Frequently, C-C bond reactions utilize expensive catalyst/ligand combinations and/or are low yielding, which can increase time and expenditures in pharmaceutical development. To enhance C-C bond formation protocols, we developed a highly efficient, selective, and combinatorially applicable Friedel-Crafts acylation to acetylate the C-3 position of imidazo[1,2-a]pyridines. The reaction, catalyzed by aluminum chloride, is both cost effective and more combinatorial friendly compared to acetylation reactions requiring multiple, stoichiometric equivalents of AlCl3. The protocol has broad application in the construction of acetylated imidazo[1,2-a]pyridines with an extensive substrate scope. All starting materials are common and the reaction requires inexpensive, conventional heating methods for adaptation in any laboratory. Further, the synthesized compounds are predicted to possess GABA activity through a validated, GABA binding model. The developed method serves as a superior route to generate C-3 acetylated imidazo[1,2-a]pyridine building-blocks for combinatorial synthetic efforts.

Entities:  

Keywords:  Combinatorial chemistry; Drug discovery; Friedel-Crafts acylation; Imidazo[1,2-a]pyridine; Library generation

Year:  2018        PMID: 30344351      PMCID: PMC6192254          DOI: 10.1016/j.tet.2018.07.027

Source DB:  PubMed          Journal:  Tetrahedron        ISSN: 0040-4020            Impact factor:   2.457


  27 in total

1.  Discovery and optimization of novel dual dithiocarbamates as potent anticancer agents.

Authors:  Ri-Dong Li; Hui-Ling Wang; Ying-Bo Li; Zhong-Qing Wang; Xin Wang; Yi-Tao Wang; Ze-Mei Ge; Run-Tao Li
Journal:  Eur J Med Chem       Date:  2015-02-20       Impact factor: 6.514

2.  The imidazopyridine derivative JK184 reveals dual roles for microtubules in Hedgehog signaling.

Authors:  Tommaso Cupido; Paul G Rack; Ari J Firestone; Joel M Hyman; Kyuho Han; Surajit Sinha; Cory A Ocasio; James K Chen
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

3.  IRAK-4 inhibitors. Part II: a structure-based assessment of imidazo[1,2-a]pyridine binding.

Authors:  George M Buckley; Thomas A Ceska; Joanne L Fraser; Lewis Gowers; Colin R Groom; Alicia Perez Higueruelo; Kerry Jenkins; Stephen R Mack; Trevor Morgan; David M Parry; William R Pitt; Oliver Rausch; Marianna D Richard; Verity Sabin
Journal:  Bioorg Med Chem Lett       Date:  2008-04-22       Impact factor: 2.823

4.  CuI-catalyzed aerobic oxidative α-aminaton cyclization of ketones to access aryl or alkenyl-substituted imidazoheterocycles.

Authors:  Yuanfei Zhang; Zhengkai Chen; Wenliang Wu; Yuhong Zhang; Weiping Su
Journal:  J Org Chem       Date:  2013-12-03       Impact factor: 4.354

5.  Structure-based design of a new class of highly selective aminoimidazo[1,2-a]pyridine-based inhibitors of cyclin dependent kinases.

Authors:  Chafiq Hamdouchi; Boyu Zhong; Jose Mendoza; Elizabeth Collins; Carlos Jaramillo; Jose Eugenio De Diego; Daniel Robertson; Charles D Spencer; Bryan D Anderson; Scott A Watkins; Faming Zhang; Harold B Brooks
Journal:  Bioorg Med Chem Lett       Date:  2005-04-01       Impact factor: 2.823

6.  A third-generation bisphosphonate, minodronic acid (YM529), augments the interferon alpha/beta-mediated inhibition of renal cell cancer cell growth both in vitro and in vivo.

Authors:  Takeshi Yuasa; Masaki Nogawa; Shinya Kimura; Asumi Yokota; Kiyoshi Sato; Hidekazu Segawa; Junya Kuroda; Taira Maekawa
Journal:  Clin Cancer Res       Date:  2005-01-15       Impact factor: 12.531

7.  Arylpiperazines as fatty acid transport protein 1 (FATP1) inhibitors with improved potency and pharmacokinetic properties.

Authors:  Tetsuyoshi Matsufuji; Mika Ikeda; Asuka Naito; Masakazu Hirouchi; Shoichi Kanda; Masanori Izumi; Jun Harada; Tsuyoshi Shinozuka
Journal:  Bioorg Med Chem Lett       Date:  2013-03-07       Impact factor: 2.823

8.  A novel imidazopyridine PI3K inhibitor with anticancer activity in non-small cell lung cancer cells.

Authors:  Hyunseung Lee; Soo Jung Kim; Kyung Hee Jung; Mi Kwon Son; Hong Hua Yan; Sungwoo Hong; Soon-Sun Hong
Journal:  Oncol Rep       Date:  2013-05-27       Impact factor: 3.906

9.  Pharmacological properties of gamma-aminobutyric acidA receptors from acutely dissociated rat dentate granule cells.

Authors:  J Kapur; R L Macdonald
Journal:  Mol Pharmacol       Date:  1996-09       Impact factor: 4.436

10.  Efficient access to 2,3-diarylimidazo[1,2-a]pyridines via a one-pot, ligand-free, palladium-catalyzed three-component reaction under microwave irradiation.

Authors:  Yuanxiang Wang; Brendan Frett; Hong-yu Li
Journal:  Org Lett       Date:  2014-05-22       Impact factor: 6.005

View more
  1 in total

1.  Superparamagnetic nanoparticle-catalyzed coupling of 2-amino pyridines/pyrimidines with trans-chalcones.

Authors:  Oanh T K Nguyen; Pha T Ha; Ha V Dang; Yen H Vo; Tung T Nguyen; Nhan T H Le; Nam T S Phan
Journal:  RSC Adv       Date:  2019-02-13       Impact factor: 4.036

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.